Making the Case: Intra-arterial Therapy for Less Common Metastases

Area of Science:

• Oncology
• Hepatology
• Interventional Radiology

Background:

• Intra-arterial therapies demonstrate significant antitumor activity in hepatic malignancies.
• Selective infusions enhance drug delivery to tumors while preserving normal liver tissue.
• These treatments are increasingly utilized in outpatient or short-stay settings for liver-dominant diseases.

Purpose of the Study:

• To review the current literature on the outcomes of intra-arterial therapies for patients with liver malignancies who are not candidates for surgery.
• To highlight the growing application of these therapies in managing refractory liver tumors.

Main Methods:

• Literature review of recent studies on intra-arterial therapy outcomes.
• Focus on nonsurgical patients with primary and secondary liver cancers.
• Analysis of data from retrospective observational cohort series.

Main Results:

• Intra-arterial therapies are effective for metastatic colorectal cancer and neuroendocrine tumors.
• These therapies are also used for secondary liver malignancies from breast cancer, melanoma, pancreatic cancer, and sarcomas.
• Current data is limited, primarily from single-institution retrospective studies.

Conclusions:

• Intra-arterial therapies are a valuable option for liver-dominant malignancies, especially in nonsurgical candidates.
• There is a critical need for multi-institutional registries and prospective data to further define outcomes.
• Continued research is essential as these therapies are increasingly used for chemorefractory tumors.